The prestigious award reflects Dr. Ralph Nachman’s decades-long devotion to the training and mentoring of early-career hematologists. He will be honored at ASH’s 58th annual meeting and exposition held on December 4.
The 25th Annual Weill Department of Medicine Awards were announced on June 29, 2016 at Medicine Grand Rounds. This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. It is supported by the Michael Wolk Foundation.
Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 22 Medicine Grand Rounds.
Dr. Jia Ruan, an Associate Professor of Clinical Medicine, who works with the The Lymphoma Clinical Research Group at Weill Cornell Medicine and NewYork-Presbyterian, has been awarded a 2016 Top 10 Clinical Research Achievement Award from the Clinical Research Forum. The award is in recognition of breakthrough research demonstrating the efficacy of an innovative combination therapy for treating mantle cell lymphoma.
Dr. Francine Garrett-Bakelman, an Instructor in Medicine in the Division of Hematology and Medical Oncology, was invited by NASA to speak on "Medical Genomics." On February 11, 2016, she delivered a talk at the Universities Space Research Association, Lunar and Planetary Institute, in Houston, Texas, reporting on medical genomic technologies, applications, and their integration into clinical care.
Dr. Lewis C. Cantley has been awarded the prestigious 2016 Wolf Prize in Medicine. Dr. Cantley, who serves as the Meyer Director of the Sandra and Edward Meyer Cancer Center, received this award in recognition of his groundbreaking discovery of the enzyme (PI3K) and the signaling pathway that it controls. Dr. Cantley found that human cancers frequently occur due to activation of PI3K, which has led to targeted drug development and clinical trials in the field of cancer.
The Mayo Clinic has received an $11 million grant from the National Cancer Institute to support research addressing current and long-term unmet healthcare needs of people with non-Hodgkin lymphoma (NHL). The is a collaborative effort among multiple institutions.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research. It is supported by the Michael Wolk Foundation.
Initiated in 2002, the Fellow Award in Research is presented annually to fellows within the Weill Department of Medicine who have presented outstanding research. This year's finalists were announced at the June 10 Medicine Grand Rounds (13th Annual).
Dr. Faltas is currently focused on molecular profiling of metastatic platinum-resistant urothelial bladder carcinoma, a disease with no approved therapies. In particular, he is investigating the molecular changes that occur as urothelial cancer evolves under the effect of chemotherapy and metastatic spread. Identifying these molecular changes will hopefully lead to finding "druggable" targets for translation into therapeutic clinical trials.
